![]() |
FDA Grants Priority Review To Cladribine Tablets For The Treatment Of Relapsing Forms
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS)...
للمزيد... |
| حسب توقيت السعودية الساعة الآن:10:24 am. |
Powered by vBulletin V3.8.6. Copyright ©2000 - 2010
MS-Saudi.com/MS-Saudi.org Copyright ©2004 - 2010